
Reset all filters
01 12Smart & Biggar LLP
Reset all filters
01 32537812
02 32758030
03 32805645
04 32834778
Reset all filters
01 12CABOZANTINIB MALATE
Reset all filters
01 12TABLET
Reset all filters
01 32024-09-24
02 32030-01-15
03 32031-07-18
04 32032-05-02
Patent Expiration Date : 2031-07-18
Date Granted : 2019-05-07
Brand Name : CABOMETYX
Patent Number : 2805645
Filing Date : 2011-07-18
Strength per Unit : 20 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2031-07-18
Date Granted : 2019-05-07
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2030-01-15
Date Granted : 2019-01-08
Brand Name : CABOMETYX
Patent Number : 2758030
Filing Date : 2010-01-15
Strength per Unit : 20 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-01-15
Date Granted : 2019-01-08
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2024-09-24
Date Granted : 2013-01-22
Brand Name : CABOMETYX
Patent Number : 2537812
Filing Date : 2004-09-24
Strength per Unit : 20 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-09-24
Date Granted : 2013-01-22
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2032-05-02
Date Granted : 2019-08-13
Brand Name : CABOMETYX
Patent Number : 2834778
Filing Date : 2012-05-02
Strength per Unit : 20 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2032-05-02
Date Granted : 2019-08-13
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2031-07-18
Date Granted : 2019-05-07
Brand Name : CABOMETYX
Patent Number : 2805645
Filing Date : 2011-07-18
Strength per Unit : 40 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2031-07-18
Date Granted : 2019-05-07
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2030-01-15
Date Granted : 2019-01-08
Brand Name : CABOMETYX
Patent Number : 2758030
Filing Date : 2010-01-15
Strength per Unit : 40 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-01-15
Date Granted : 2019-01-08
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2024-09-24
Date Granted : 2013-01-22
Brand Name : CABOMETYX
Patent Number : 2537812
Filing Date : 2004-09-24
Strength per Unit : 40 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-09-24
Date Granted : 2013-01-22
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2032-05-02
Date Granted : 2019-08-13
Brand Name : CABOMETYX
Patent Number : 2834778
Filing Date : 2012-05-02
Strength per Unit : 40 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2032-05-02
Date Granted : 2019-08-13
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2031-07-18
Date Granted : 2019-05-07
Brand Name : CABOMETYX
Patent Number : 2805645
Filing Date : 2011-07-18
Strength per Unit : 60 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2031-07-18
Date Granted : 2019-05-07
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2030-01-15
Date Granted : 2019-01-08
Brand Name : CABOMETYX
Patent Number : 2758030
Filing Date : 2010-01-15
Strength per Unit : 60 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-01-15
Date Granted : 2019-01-08
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF